It is commonly prescribed in the United Kingdom for the management of type 2 diabetes mellitus, either as monotherapy (when metformin is contraindicated or not tolerated) or in combination with other glucose-lowering agents
Umapathysivam MM, Lee MY, Jones KL, Annink CE, Cousins CE, Trahair LG, Rayner CK, Chapman MJ, Nauck MA, Horowitz M, Deane AM (2014) Comparative effects of prolonged and intermittent stimulation of the Glucagon-Like peptide 1 receptor on gastric emptying and Glycemia
The buzz around these medicines has a lot of patients asking for more information about GLP-1s
Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue
Nair KS, Halliday D, Matthews DE, Welle SL
What is the treatment for CTD